Advanced delivery options in Parkinson's
Subcutaneous levodopa, deep brain stimulation, and continuous infusion are reshaping how advanced Parkinson's disease is managed.
Advanced Parkinson's care has moved beyond oral levodopa optimisation. Subcutaneous infusion and deep brain stimulation are becoming routine in selected patients, but the access pattern - which centres offer them, who gets referred, when - is what determines real-world reach.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
- ExplainedWhat is spasticity?
- SnapshotAcute ischemic stroke therapy reference (2026)
- ExplainedAcute ischemic stroke explained
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.